BI 1584862
BI 1584862 is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems
A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood
Clinical Trials (6)
A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems
A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood
A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6